healthcare IPO pipeline 2026

The healthcare IPO pipeline for 2026 is shaping up against a complex backdrop of selective capital markets, heightened regulatory scrutiny, and renewed investor interest in platform-driven biotechnology. After two years of constrained public offerings, issuers are recalibrating timelines, clinical milestones, and valuation expectations to align with a more disciplined Nasdaq environment. Unlike the pandemic-era boom, … Read more